Pathology consultation on vitamin D testing: Clinical indications for 25(OH) vitamin D measurement

American Journal of Clinical Pathology

Volumn 137, Issue 5, 2012, Pages 831-832

  Chuanyi, M Lu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; GLUCOCORTICOID; VITAMIN D;

ANTICONVULSANT THERAPY; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; HUMAN; HYPERPARATHYROIDISM; LETTER; LIVER DISEASE; OBESITY; OSTEOMALACIA; OSTEOPOROSIS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RICKETS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; MALE; NOTE; PATHOLOGY; STANDARD;

HUMANS; MALE; PATHOLOGY, CLINICAL; VITAMIN D DEFICIENCY;

EID: 84862627858     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP2GP0GHKQRCOE     Document Type: Letter

References (4)

1. Krasowski MD. Pathology consultation on vitamin D testing. Am J Clin Pathol. 2011;136:507-514.
2. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
4. Holick MF. The D-lemma: to screen or not to screen for 25-hydroxyvitamin D concentrations. Clin Chem. 2010;56:729-731.